More from Medscape

• ADA 2019CGM During Type 1 Diabetes Pregnancy Makes Substantial Cost Savings Over Fingerprick Testing Care of pregnant mothers with type 1 diabetes and their newborns costs significantly less with use of continuous glucose monitoring than with conventional fingerprick testing, UK researchers said.
  Medscape News UK, June 2019
• EHA 2019Novel Drug Could Be 'Disease Modifying' in Sickle Cell Disease An investigational agent, the first-in-class drug voxelotor, is seen as potentially ‘disease-modifying' as it targets mechanisms that cause anemia.
  Medscape Medical News, June 2019
• EULAR 2019Imaging Can Mislead in Inflammatory Arthritis Tests can help clinicians assess patients with suspected inflammatory arthritis, but 'it shouldn't drive' treatment, an expert reminds rheumatologists.
  Medscape Medical News, June 2019
• CMSC 2019ORACLE-MS: Cladribine Effective in MS Subgroups The recently approved disease-modifying therapy is expected to find a niche for patients with multiple sclerosis who fail other agents.
  Medscape Medical News, June 2019
• EHA 2019Measurable Residual Disease in AML Ups Post-HSCT Relapse Risk Measurable residual disease, detected with next-generation genomic sequencing, is associated with a significantly increased risk for relapse. Experts question the prognostic ability of other assessment tools.
  Medscape Medical News, June 2019
• Shorter-term Herceptin Sufficient? No Agreement Different conclusions have been drawn from similar findings, perhaps as a result of subjective margins for equivalence in HER2+ breast cancer research.
  Medscape Medical News, June 2019
• WCD 2019Spotting Difficult-to-Diagnose Skin Cancers Hard-to-identify lesions can lead to clinical misses and misdiagnoses. Specialists attending the World Congress of Dermatology discuss 'great masqueraders' and what to do about them.
  Medscape Medical News, June 2019
• ADA 2019Large UK Audit of FreeStyle Libre: Improved HbA1c, Marked Drop in Admissions UK audit of FreeStyle Libre shows a drop in HbA1c, a reduction in hypoglycaemia rate including nocturnal hypos, reduced duration of hypos, and reduced hospital admissions for diabetic ketoacidosis, hyperglycaemia and hypoglycaemia.
  Medscape News UK, June 2019
• Rates of Self-Harm Soar, Especially Among Girls, Young Women Rates of nonsuicidal self-harm have tripled since 2000, especially among adolescent girls and young women.
  Medscape Medical News, June 2019
• Alcohol Consumption and Risk of COPD How might alcohol consumption impact the risk of COPD in men--and does risk differ by alcohol type?
  American Journal of Epidemiology, June 2019
• Last Nail in the Coffin for Sugar Drinks: Now the Hard Part Despite all the serious health risks, why are people so motivated to drink sugared beverages?
  Circulation, June 2019
• ASCO 2019Liquid Biopsies Predict Early ER+ Breast Cancer Progression Biomarkers in ctDNA "could detect right at the start of treatment women whose cancers were most likely to develop resistance quickly to palbociclib". Nicholas Turner, Institute of Cancer Research.
  Medscape News UK, June 2019
• ASCO 2019No Survival Benefit With Immunotherapy in TN Breast Cancer The "modest" improvement in progression-free survival means that atezolizumab is "certainly reasonable" as a first-line therapy in metastatic patients, says Cesar Santa-Maria, Northwestern University.
  Medscape Medical News, June 2019
• EAACI 2019Emollients Fail to Protect Against Eczema Results from two large clinical trials have dermatologists debating the value of creams for preventing or delaying eczema and questioning the next steps in clinical practice.
  Medscape Medical News, June 2019
• EAS 2019Undiagnosed FH Linked to 16-Year Life Expectancy Reduction The high premature cardiovascular death risk in undiagnosed familial hypercholesterolemia (FH) supports the case for earlier cholesterol screening, investigators say.
  Medscape Medical News, June 2019
• ASCO 2019Novel Drug for Advanced Urothelial Cancer: Enfortumab Vedotin Enfortumab vedotin could become the 'next-in-line' treatment for patients with advanced and metastatic urothelial cancer, in whom there is a 'high unmet need.'
  Medscape Medical News, June 2019
• ESOC 2019Novel Per-conditioning Strategy Disappoints in Stroke The concept of inducing transient ischemia in a different part of the body in an attempt to protect the brain from the larger ischemic insult of a stroke was not successful in the RESCUE BRAIN study.
  Medscape Medical News, June 2019
• Alert UK's MHRA Offers Split Recs on Paclitaxel-Coated Devices in PAD The agency acted to limit the future use of the devices in routine clinical care of intermittent claudication but left open their use in critical limb ischemia.
  News Alerts, June 2019
• ASCO 2019Free Online Tool Predicts Late ER+ Breast Cancer Recurrence Clinical calculator could spare breast cancer patients 5 years of unnecessary hormone therapy.
  Medscape News UK, June 2019
• ESOC 2019Mixed ICH Patients at Higher Risk of Disability Mixed ICH, showing features of both lobar and deep ICH, appears to carry risk for worse outcomes than those with strictly lobar or deep ICH presentation, new research suggests.
  Medscape Medical News, June 2019